新冠疫情期高危产科远程医疗的依从性与可接受性
该研究通过两份自填问卷(91份患者、33份提供者)调查高危产科远程医疗的态度,并比较2019与2020年同期预约出席、取消与爽约率。结果显示患者与提供者满意度高,实施远程医疗后爽约与取消率显著降低。
要点
- 86.9%患者满意远程医疗,78.3%愿意推荐给他人
- 实施远程医疗后爽约率由8.49%降至4.61%(P<.001)
- 73.8%患者希望孕期采用线下与远程结合模式
核心结论
- 在高危产科实施远程医疗模型可减少错过预约,从而可能改善高危产科医疗可及性。
- 患者与提供者均对远程医疗访视满意度高,并希望将远程医疗整合进传统高危产科照护模式。
研究设计与样本
- 两项自填问卷:第一份发送给2020年3月1日至5月30日期间接受远程医疗访视的全部高危产科患者,第二份面向参与这些访视的提供者。
- 比较远程医疗实施前(2019年3月1日至5月30日)与实施后(2020年同期)的出席、取消与爽约率,并比较2020年远程医疗与面对面访视。
- 回顾的预约包括高危产前保健预约、糖尿病教育课程、遗传咨询与母胎医学会诊。
主要发现
- 共分析91份患者问卷和33份提供者问卷。
- 86.9%患者对所接受照护满意,78.3%会向他人推荐远程医疗访视。
- 87.8%提供者报告使用远程医疗体验积极,90.9%认为远程医疗改善患者获得照护的机会。
- 73.8%患者希望孕期采用面对面与远程医疗结合的访视方式;提供者中偏好面对面者显著多于偏好远程医疗者(56% vs 23%,P=.024)。
- 与2019年相比,2020年实施远程医疗后爽约率(8.49% vs 4.61%,P<.001)、患者取消预约率(7.06% vs 4.96%,P<.001)与患者当日取消率(2.30% vs 1.35%,P<.001)均显著降低。
临床怎么用
- 在高危产科可将远程医疗作为传统面对面照护的补充,以减少爽约与取消。
- 患者偏好混合模式,提供者更偏好面对面,安排访视时需兼顾双方偏好。
- 远程医疗适用于糖尿病教育、遗传咨询与母胎医学会诊等预约类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Telehealth has been successfully implemented for the delivery of obstetrical care. However, little is known regarding the attitudes and acceptability of patients and providers in high-risk obstetrics and whether the implementation of a telehealth model improves access to care in nonrural settings. OBJECTIVE: This study aimed to describe patient and provider attitudes toward telehealth for the delivery of high-risk obstetrical care in a large healthcare system with both urban and suburban settings and to determine whether the implementation of a telehealth model improves patient adherence to scheduled appointments in this patient population. STUDY DESIGN: Two self-administered surveys were designed. The first survey was sent to all high-risk obstetrical patients who received a telehealth visit between March 1, 2020, and May 30, 2020. The second survey was designed for providers who participated in these visits. We also compared the attended, cancelled, and no-show visit rates before (March 1 to May 30, 2019) and after (March 1 to May 30, 2020) the telehealth implementation and telehealth vs in-person visits in 2020. We reviewed scheduled high-risk prenatal care appointments, diabetes mellitus education sessions, and genetic counseling and Maternal-Fetal Medicine consultations. RESULTS: A total of 91 patient surveys and 33 provider surveys were analyzed. Overall, 86.9% of patients were satisfied with the care they received and 78.3% would recommend telehealth visits to others. Notably, 87.8% of providers reported having a positive experience using telehealth, and 90.9% believed that telehealth improved patients' access to care. When comparing patient and provider preference regarding future obstetrical care after experiencing telehealth, 73.8% of patients desired a combination of in-person and telehealth visits during their pregnancy. However, a significantly higher rate of providers preferred in-person than telehealth visits (56% vs 23%, P=.024, respectively). When comparing visits between 2019 and 2020, there was a significantly lower rate of no-show appointments (8.49% vs 4.61%, P<.001), patient-cancelled appointments (7.06% vs 4.96%, P<.001), and patient same-day cancellations (2.30% vs 1.35%, P<.001) with the implementation of telehealth. There was also a significantly lower rate of patient-cancelled appointments (3.82% vs 5.44%, P=.021) and patient same-day cancellations (0.60% vs 1.65%, P=.002) with those receiving telehealth visits than in-person visits in 2020. CONCLUSION: The implementation of a telehealth model in high-risk obstetrics has the potential to improve access to high-risk obstetrical care, by reducing the rate of missed appointments. Both patients and providers surveyed expressed a high rate of satisfaction with telehealth visits and a desire to integrate telehealth into the traditional model of high-risk obstetrical care.
引用
- Jeganathan S, Prasannan L, Blitz MJ, et al. Adherence and acceptability of telehealth appointments for high-risk obstetrical patients during the coronavirus disease 2019 pandemic. Am J Obstet Gynecol MFM. 2020. PMID: 32984803. doi:10.1016/j.ajogmf.2020.100233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。